Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „receiving“
Suchtreffer
Begriffe & Kennungen
Abseamed · 4.8 · An increased incidence of thrombotic vascular events (TVEs) has been observed in patients receiving ESAs (see
Eintrag öffnenAdcetris · 4.8 · Adverse events led to treatment discontinuation in 24% of patients receiving ADCETRIS.
Eintrag öffnenAdcetris · 4.8 · In patients receiving ADCETRIS combination therapy, serious adverse reactions occurred in 34% of patients. Ser
Eintrag öffnenAdcetris · 4.8 · Serious adverse reactions occurred in 39.4% patients receiving BrECADD treatment, and 36.4% in patients who re
Eintrag öffnenAdcetris · 4.8 · Serious cardiac adverse reactions occurred in 2.7% of patients receiving BrECADD and 1.1% of patients receivin
Eintrag öffnenAdvagraf · 4.8 · Immune system disorders Allergic and anaphylactoid reactions have been observed in patients receiving tacrolim
Eintrag öffnenAdvagraf · 4.8 · Infections and infestations As is well known for other potent immunosuppressive agents, patients receiving tac
Eintrag öffnenAdvagraf · 4.8 · Neoplasms benign, malignant and unspecified (incl. cysts and polyps) Patients receiving immunosuppressive ther
Eintrag öffnenAerinaze · 4.3 · As Aerinaze contains pseudoephedrine sulphate, it is also contraindicated in patients who are receiving monoam
Eintrag öffnenAfinitor · 4.5 · Potentiation of radiation treatment toxicity has been reported in patients receiving everolimus (see sections
Eintrag öffnenAlli (previously Orlistat GSK) · 4.5 · The vast majority of subjects receiving up to 4 full years of treatment with orlistat in clinical studies had
Eintrag öffnenAloxi · 4.8 · Adverse reactions were evaluated in paediatric patients receiving palonosetron for up to 4 chemotherapy cycles
Eintrag öffnenAmbirix · 4.5 · It may be expected that in patients receiving immunosuppressive treatment or patients with immunodeficiency, a
Eintrag öffnenApixaban Accord · 4.5 · Apixaban is not recommended for the treatment of DVT and PE in patients receiving concomitant systemic treatme
Eintrag öffnenApixaban Accord · 4.5 · The use of apixaban is not recommended in patients receiving concomitant systemic treatment with strong inhibi
Eintrag öffnenApixaban Accord · 4.5 · The use of apixaban is not recommended in patients receiving concomitant systemic treatment with strong inhibi
Eintrag öffnenAranesp · 4.8 · Convulsions have been reported in patients receiving darbepoetin alfa (see section 4.4). The frequency is esti
Eintrag öffnenAranesp · 4.8 · Convulsions have been reported in patients receiving darbepoetin alfa in post-marketing experience (see sectio
Eintrag öffnenArava · 4.5 · If the patient is already receiving nonsteroidal anti-inflammatory drugs (NSAIDs) and/or corticosteroids, thes
Eintrag öffnenArava · 4.5 · If the patient is already receiving nonsteroidal anti-inflammatory drugs (NSAIDs) and/or corticosteroids, thes
Eintrag öffnen